Julia Eastland

Ms. Julia M.
Eastland is a President, Chief Executive Officer & Director at Zentalis Pharmaceuticals, Inc., an Independent Director at Lantheus Holdings, Inc., an Independent Director at Seismic Therapeutic, Inc. and an Independent Director at Veana Therapeutics, Inc. She is on the Board of Directors at Zentalis Pharmaceuticals, Inc., Lantheus Holdings, Inc., Seismic Therapeutic, Inc. and Veana Therapeutics, Inc. Ms. Eastland was previously employed as a Chief Operating & Financial Officer by ReCode Therapeutics, Inc., an Independent Director by Graybug Vision, Inc., an Independent Director by Dynavax Technologies Corp., a President, CEO, Secretary & Director by Harpoon Therapeutics, Inc., a Chief Financial & Business Officer by Rainier Therapeutics, Inc., a CFO, Secretary & VP-Corporate Development by CASCADIAN THERAPEUTICS INC, a Chief Financial Officer & VP-Operations by Viral Logic Systems Technology Corp., a Vice President-Strategic Planning by Dendreon Corp., a Controller by Amgen, Inc., a Finance Director by Biovail Corp., a Financial Manager by Discovery Channel, a Director-Finance & Planning by Encore Media Group, and a Manager-Business & International Finance by Science Magazine.
She also served on the board at Pascal Biosciences, Inc. She received her undergraduate degree from Colorado State University and an MBA from the University of Edinburgh Business School.